ArticleJournal of neurology2025

Methotrexate therapy as a promising long-term treatment approach for immune-mediated adverse reactions of tofersen in SOD1-ALS: a case report.

Maximilian Vidovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.